Age and Mental Health Predict Early Device-Specific Quality of Life in Patients Receiving Prophylactic Implantable Defibrillators

Canadian Journal of Cardiology

Volumn 28, Issue 4, 2012, Pages 502-507

  Carroll, Sandra L ^a   Markle Reid, Maureen ^a   Ciliska, Donna ^a   Connolly, Stuart J ^a   Arthur, Heather M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CARDIAC PATIENT; DEFIBRILLATOR; DEPRESSION; FEMALE; FLORIDA PATIENT ACCEPTANCE SCALE; GENDER; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL PARAMETERS; MENTAL HEALTH; PERSONALITY; POSTIMPLANT; PREDICTION; PREIMPLANT; PRIMARY PREVENTION; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME;

AGE FACTORS; AGED; CHARACTER; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; DEPRESSIVE DISORDER; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; ONTARIO; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 84863881517     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.01.008     Document Type: Article

References (41)

1. Nanthakumar K., Epstein A.E., Kay G.N., Plumb V.J., Lee D.S. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 2004, 44:2166-2172.
2. Epstein A.E., DiMarco J.P., Ellenbogen K.A., et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 51:e1-e62.
3. Hauser R.G. The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J Am Coll Cardiol 2005, 45:2022-2025.
4. Burns J.L., Serber E.R., Keim S., Sears S.F. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol 2005, 16:384-390.
5. Dunbar S.B., Langberg J.J., Reilly C.M., et al. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysio 2009, 32:1259-1271.
6. Pedersen S.S., van Domburg R.T., Theuns D.A.M.J., Jordaens L., Erdman R.A.M. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom Med 2004, 66:714-719.
7. Sears S.F.P., Serber E.R.M., Lewis T.S.P., et al. Do positive health expectations and optimism relate to quality-of-life outcomes for the patient with an implantable cardioverter defibrillator?. J Cardiopulm Rehabil 2004, 24:324-331.
8. Pedersen S.S., Theuns D.A., Muskens-Heemskerk A., Erdman R.A., Jordaens L. Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation. Europace 2007, 9:675-680.
9. Rudisch B., Nemeroff C.B. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003, 54:227-240.
10. Dunbar S.B. Psychosocial issues of patients with implantable cardioverter defibrillators. Am J Crit Care 2005, 14:294-303.
11. Sears S.F., Todaro J.F., Lewis T.S., Sotile W., Conti J.B. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol 1999, 22:481-489.
12. Thomas S.A., Friedmann E., Kao C., et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care 2006, 15:389-398.
13. Strickberger S.A., Hummel J.D., Bartlett T.G., et al. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol 2003, 41:1707-1712.
14. Passman R., Subacius H., Ruo B., et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med 2007, 167:2226-2232.
15. Piotrowicz K., Noyes K., Lyness J.M., et al. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II. Eur Heart J 2007, 28:601-607.
16. Smith T.W., Gallo L.C. Personality traits as risk factor for physical illness. Handbook of Health Psychology 2001, 139-173. Erlbaum, Mahwah, NJ. A.R.T.A.S.J. Baum (Ed.).
17. Healey J.S., Hallstrom A.P., Kuck K.H., et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J 2007, 28:1746-1749.
18. Lee D.S., Tu J.V., Austin P.C., et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 2007, 49:2408-2415.
19. Bilge A.K., Ozben B., Demircan S., Cinar M., Yilmaz E., Adalet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 2006, 29:619-626.
20. Sowell L.V., Sears S.F., Walker R.L., Kuhl E.A., Conti J.B. Anxiety and marital adjustment in patients with implantable cardioverter defibrillator and their spouses. J Cardiopulm Rehabil 2007, 27:46-49.
21. Sowell L.V., Kuhl E.A., Sears S.F., Klodell J., Conti J.B. Device implant technique and consideration of body image: specific procedures for implantable cardioverter defibrillators in female patients. J Womens Health 2006, 15:830-835.
22. Burns J.L., Sears S.F., Sotile R., et al. Do patients accept implantable atrial defibrillation therapy?. results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) study. J Cardiovasc Electrophysiol 2004, 15:286-291.
23. Pedersen S.S., Spindler H., Johansen J.B., Mortensen P.T., Sears S.F. Correlates of patient acceptance of the cardioverter defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients. Pacing Clin Electrophysiol 2008, 31:1168-1177.
24. Radloff L.S. The CES-D scale: A self-report depression scale for research in the general population. Appl Psych Meas 1977, 1:385-401.
25. Weissman M.M., Sholomskas D., Pottenger M., Prusoff B.A., Locke B.Z. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977, 106:203-214.
26. Beekman A.T., Deeg D.J., Van L.J., Braam A.W., De Vries M.Z., Van T.W. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Psychol Med 1997, 27:231-235.
27. Scheier M.F., Carver C.S. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol 1985, 4:219-247.
28. Scheier M.F., Carver C.S., Bridges M.W. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 1994, 67:1063-1078.
29. McHorney C.A., Ware J.E., Raczek A.E. The MOS 36-Item Short-Form Health Survey (SF-36): II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247-263.
30. McHorney C.A., War J.E., Lu J.F.R., Sherbourne C.D. The MOS 36-Item Short-Form Health Survey (SF-36): III. tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994, 32:40-66.
31. Norman G.R., Streiner D.L. Biostatistics: The Bare Essentials 2008, BC Decker, Hamilton, ON. 3rd ed.
32. Tabachnick B.G., Fidell L.S. Using Multivariate Statistics 2001, Allyn &Bacon, Needham Heights, MA. 4th ed.
33. Ware J.E., Kosinski M., Bjorner J.B., Turner-Bowker D.M., Gandek B., Maruish M.E. User's Manual for the SF-36v2 Health Survey 2008, Quality Metric, Lincoln, RI. 2nd ed.
34. Schein R.L., Koenig H.G. The Center for Epidemiological Studies Depression (CES-D) scale: assessment of depression in the medically ill elderly. Int J Geriatr Psychiatry 1997, 12:436-446.
35. Spindler H., Johansen J.B., Andersen K., Mortensen P., Pedersen S.S. Gender differences in anxiety and concerns about the cardioverter defibrillator. Pacing Clin Electrophysiol 2009, 32:614-621.
36. Birnie D.H., Sears S.F., Green M.S., Lemery R., Gollob M.H., Amyotte B. No long-term psychological morbidity living with an implantable cardioverter defibrillator under advisory: the Medtronic Marquis experience. Europace 2009, 11:26-30.
37. Groeneveld P.W., Matta M.A., Suh J.J., Yang F.E., Shea J.A. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era. Pacing Clin Electrophysiol 2007, 30:463-471.
38. Mark D.B., Anstrom K.J., Sun J.L., et al. quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008, 359:999-1008. Sudden cardiac death in heart failure trial investigators.
39. Katon W., Lin E.H., Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007, 29:147-155.
40. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883. Multicenter Automatic Defibrillator Implantation Trial II Investigators.
41. Smith G., Dunbar S.B., Valderrama A.L., Viswanathan B. Gender differences in implantable cardioverter-defibrillator patients at the time of insertion. Prog Cardiovasc Nurs 2006, 21:76-82.